Viewing Study NCT01240967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-02-01 @ 5:11 AM
Study NCT ID: NCT01240967
Status: COMPLETED
Last Update Posted: 2014-03-17
First Post: 2010-11-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
None Patients View
None Pharmacokinetics View
None Renal Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None healthy volunteers View
None volunteers with renal impairment View
None pharmacokinetics View
None TC-5214 View